Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-03
2007-07-03
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S406000, C548S263200, C548S265400
Reexamination Certificate
active
10766388
ABSTRACT:
The present invention relates to use of 1-carbamoylazole derivatives as medicaments and pharmaceutical compositions containing 1-carbamoylazole derivatives as the active ingredient, based on their DPPIV inhibiting effects. The present invention provides a dipeptidyl peptidase IV inhibiting agent comprising a compound represented by the general formula (I):
REFERENCES:
patent: 5510320 (1996-04-01), Tseng
patent: 6492301 (2002-12-01), Hacker et al.
Ikuta Hironori
Koyanagi Mika
Nagakura Tadashi
Okada Toshimi
Yamazaki Kazuto
Eisai R & D Management Co. Ltd.
Morgan & Finnegan , LLP
Saeed Kamal A.
LandOfFree
Pharmaceutical use of N-carbamoylazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical use of N-carbamoylazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical use of N-carbamoylazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3776905